Search Results for "Wockhardt Europe Ltd"

14:48 EST 6th December 2016 | BioPortfolio

Matching Channels


The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...


Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...


AA amyloidosis affects approximately 35,000 - 50,000 individuals in the United States, Europe (Top 5 countries) and Japan. The disease occurs in a subset of patients with long-lasting inflammatory c...


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Phoenix MarCom

Phoenix MarCom is a specialist marketing communications company, working with clients in the clean tech (including renewables, environmental technology, low carbon and sustainability), scientific an...

Matching News

Third strike for Wockhardt as API facility hit with US import alert

The US FDA has banned products from a third Indian manufacturing plant operated by Wockhardt.

Wockhardt UK sterile site hit with FDA warning

Mumbai-based pharmaceutical and biotechnology firm Wockhardt has been hit with more manufacturing woes as the FDA issued a warning letter against the company concerning the processes at its facility i...

Wockhardt consolidated net dips by 83% in Q1 to Rs. 16 cr

Wockhardt, a Rs. 4,450 crore plus pharma major, has suffered heavy setback during the first quarter ended June 2016 and its consolidated net profit declined sharply by 82.7 per cent to Rs. 15.89 crore...

Wockhardt Introduces LabHQ LIMS for Quality Control

Global pharmaceutical and biotechnology company Wockhardt has chosen the latest version of Broughton Software’s LabHQ LIMS for its new quality control laboratories in Wrexham. This intuitive sof...

Wockhardt to up manufacturing capacity at Wrexham site

Wockhardt has said it will build a sterile manufacturing and drug testing facility at its site in Wrexham, Wales.

US FDA calls Wockhardt efforts to fix Wrexham plant 'inadequate'

Efforts by Wockhardt to fix violations at drug plant in Wrexham, Wales are inadequate according to the US FDA which detailed its concerns in a warning letter this week.

Novartis Galvus India Case: Wockhardt Pulls Back?

Legal proceedings around Novartis' Galvus patent in India appear to have taken an interesting turn, with generic challenger Wockhardt indicating...  

Wockhardt data may delay US solithromycin review says Cempra after asking Uquifa for CMC info

Cempra has asked Uquifa for API manufacturing data to support its US solithromycin efforts after raising concerns that information from Wockhardt in the current dossier will delay review.

Matching PubMed Articles

Longitudinal Predictors of Functional Impairment in Older Adults in Europe - Evidence from the Survey of Health, Ageing and Retirement in Europe.

To examine time-dependent predictors of functional impairment in older adults in Europe longitudinally.

The genetic history of Ice Age Europe.

Modern humans arrived in Europe ~45,000 years ago, but little is known about their genetic composition before the start of farming ~8,500 years ago. Here we analyse genome-wide data from 51 Eurasians ...

Dirofilaria repens Microfilaremia in Three Dogs in Estonia.

In Europe, the zoonotic parasite Dirofilaria repens continues to spread northward. We describe three likely autochthonous canine microfilaremic D. repens infections from Estonia, an European Union cou...

Dengue and other Aedes-borne viruses: a threat to Europe?

Corrigendum to "EuReCa ONE-27 Nations, ONE Europe, ONE Registry A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe" Resuscitation 105 (2016) 188-195.

Search Whole site using Google

Quick Search
Advertisement Advertisement